Crystec announced as finalists for two CPhI Excellence in Pharma Awards 2018
Crystec are delighted to have been selected as finalists for the CPhI Excellence in Pharma Awards for the second year running. Having been awarded CPhI Excellence in Pharma for Contract Services and Outsourcing in 2017, we are delighted that our applications have progressed to the final selection stage.
The shortlisted entries are for Excellence in Pharma: Formulation (“’In-particle formulation design’ using mSAS technology”) and Excellence in Pharma: Manufacturing Technology and Equipment (“mSAS technology - a particle engineering solution to optimise and simplify inhaled products”). A full list of finalists can be found at https://awards.cphi.com/finalists/ and the winners will be announced on Tuesday 9th October during the Awards gala at CPhI in Madrid.
For more information about Crystec’s modified supercritical anti-solvent (mSAS) technology or to book at meeting during CPhI in Madrid, please contact Emily Bevis (firstname.lastname@example.org).